scholarly journals The ideal approach of ovarian dermoid cyst excision; the predicament of laparoscopy versus laparotomy

2021 ◽  
Vol 12 (4) ◽  
pp. 205-210
Author(s):  
Kamil Mosa Fram ◽  
Shawqi S Saleh ◽  
Nadia A Muhaidat ◽  
Farah K Fram ◽  
Rand K Fram ◽  
...  

Purpose: The aim of the current retrospective study for reviewing the cases of dermoid cyst managed at our hospital during the study period, to find out the best and safest management approach after taking in consideration the related factors. Setting: This analysis took place at the department of Gynecology and Obstetrics at Jordan University Hospital. Material and methods: The retrospective records were reviewed for over 6 years (from January 2015 to January 2021). The sample of study included a total number of 87 patients operated with ovarian dermoid. Thirty-five patients (40.22%) presented with abdominal mass, 16 patients (18.39%) were accidently found to have this kind of ovarian cysts, 12 patients (13.79%) presented with pressure symptoms, 11 patients (12.64%) presented with dyspareunia and dysmenorrhea, 8 patients (09.19%) with abdominal pain, and 5 patients (05.74%) with recurrent attacks of nausea. Thirty-nine patients (44.83%) treated by laparotomy, another 39 patients (44.83%), the management procedure completed laparoscopically, and 9 patients (10.34%), the procedure started laparoscopically, then converted to laparotomy. Sixty-one patients (70.11%) were found to have right sided ovarian dermoid, while 19 patients (21.84%) were found to have bilateral, and 7 patients (08.05%) were found to have left sided one. The size of the cyst was more than 11 cm in 40 patients (45.98%), while less than 5 cm in 5 patients (5.75%). Results: ovarian cystectomy performed in 70 patients (80.46%), and salpingo-oophorectomy on 17 patients (19.54%) on both reproductive and postmenopausal group. The average blood loss and operative time were more on the laparoscopic group; 298.7 ml, 98.8 minutes respectively. Conclusion: Laparotomy and ovarian cystectomy seems to be superior to other methods of management for ovarian dermoid, particularly when the size of the cyst is more than 5 cm, and predominantly the cysts presentation bilaterally.

2018 ◽  
Vol 159 (6) ◽  
pp. 981-986 ◽  
Author(s):  
Jin Pyeong Kim ◽  
Dong Kun Lee ◽  
Jeong Hwan Moon ◽  
Jung Je Park ◽  
Seung Hoon Woo

Objective Transoral surgery is becoming a preferred technique because it does not leave any scar after surgery. However, transoral surgery for a dermoid cyst of the oral cavity is not standardized yet, due to the anatomic complexity of this region. The aim of this study was to evaluate the safety and efficacy of a transoral dermoid cyst excision. Study Design Multicenter prospective observational study. Setting University hospital. Subjects and Methods This study was designed as a 4-year prospective multicenter evaluation of dermoid cyst excisions within the floor of mouth. Clinical outcomes and complications related to procedures were evaluated among patients. The primary outcome was the efficacy of the procedure, and the secondary outcome was cosmetic satisfaction of each procedure. Results Twenty-one patients underwent transoral dermoid cyst excisions, and 22 underwent transcervical excisions. In the transoral surgery group, the mean size of the dermoid cyst was 5.35 cm (95% CI, 4.79-5.91), and in the transcervical surgery group, it was 6.19 cm (95% CI, 5.67-6.71). There was no significant differences with respect to overall demographic characteristics between the groups. However, the duration of the operation was shorter with the transoral group than with the transcervical group ( P = .001), and cosmetic satisfaction was much better in the transoral group ( P < .001). Conclusion Transoral dermoid cyst excision is a potentially safe and effective method that can lead to easy and quick removal of an oral cavity dermoid cyst, with excellent cosmetic outcomes.


1993 ◽  
Vol 21 (3) ◽  
pp. 275-279 ◽  
Author(s):  
John Turnbull

Polydipsia is a disorder that has received little attention in the research literature. Treatment has been mainly confined to medical or pharmacological intervention. Few studies have reported the use of contingency management techniques and none have sought to encourage self-management. This study shows how such a procedure brought about a significant change in rates of water drinking in a thirty-one year old man with a mild learning disability.


2018 ◽  
Vol 7 ◽  
Author(s):  
Mie Shiraishi ◽  
Megumi Haruna ◽  
Masayo Matsuzaki ◽  
Ryoko Murayama ◽  
Satoshi Sasaki

AbstractDietary under-reporting is a common problem when using self-reported dietary assessment tools. However, there are few studies regarding under-reporting during pregnancy. This study aimed to explore the demographic and psychosocial characteristics related to dietary under-reporting in pregnant Japanese women. A cross-sectional study was conducted between 2010 and 2011 at a university hospital in Tokyo, Japan. Nutrient intake was assessed using a self-administered Diet History Questionnaire (DHQ), which had questions about the consumption frequency and portion size of selected food items. The 24-h urinary excretion levels of urea N and K were used as the dietary protein and K intake reference values, respectively. Under-reporting of protein and K was defined as the bottom 25 % of the reporting accuracy (the ratio of reported intake on the DHQ to the estimated intake based on urinary excretion). Under-reporters were defined as participants who under-reported both protein and K intake. Multiple logistic regression analysis was performed to examine the factors associated with under-reporters. Of 271 healthy women at 19–23 weeks of gestation, thirty-five participants (12·9 %) were identified as under-reporters. Under-reporters had a lower pre-pregnancy BMI (adjusted OR (AOR) = 0·81) and lower gestational weight gain (AOR = 0·82); they also reported managing their gestational weight gain with the aim to return to their pre-pregnancy weight soon after childbirth (AOR = 2·99). Healthcare professionals should consider the potential for dietary under-reporting and the possible related factors when assessing the dietary intakes of pregnant Japanese women using self-administered questionnaires.


2016 ◽  
Vol 3 (1) ◽  
pp. 231-248
Author(s):  
Ashgan Elgohary ◽  
Kamelia Abd–Allah ◽  
Fawzy Megahed Khalil Fawzy Megahed Khalil ◽  
Samah Ghonaem

Author(s):  
Martin Simko ◽  
Adrian Totka ◽  
Diana Vondrova ◽  
Martin Samohyl ◽  
Jana Jurkovicova ◽  
...  

This study aimed to evaluate the impact of selected pregnancy pathologies statistically depending on overweight/obesity and excessive maternal weight gain during pregnancy on women who gave birth in the years 2013–2015 at the Second Department of Gynecology and Obstetrics at the University Hospital in Bratislava, Slovakia. In a retrospective study, we analyzed data gathered from the sample, which consisted of 7122 women. Our results suggest a statistically significant, higher risk for the groups of women with overweight and obesity and gestational hypertension (adjusted odds ratio (AOR) = 15.3; 95% CI 9.0−25.8 for obesity), preeclampsia (AOR = 3.4; 95% CI 1.9−6.0 for overweight and AOR = 13.2; 95% CI 7.7−22.5 for obesity), and gestational diabetes mellitus (AOR = 1.9; 95% CI 1.2−2.9 for overweight and AOR = 2.4; 95% CI 1.4−4.0 for obesity). A higher incidence of pregnancies terminated by cesarean section was observed in the group of obese women. Gestational weight gain above IOM (Institute of Medicine) recommendations was associated with a higher risk of pregnancy terminated by C-section (AOR = 1.2; 95% CI 1.0−1.3), gestational hypertension (AOR = 1.7; 95% CI 1.0−2.7), and infant macrosomia (AOR = 1.7; 95% CI 1.3−2.1). Overweight and obesity during pregnancy significantly contribute to the development of pregnancy pathologies and increased incidence of cesarean section. Systematic efforts to reduce weight before pregnancy through prepregnancy dietary counseling, regular physical activity, and healthy lifestyle should be the primary goal.


BMJ Open ◽  
2019 ◽  
Vol 9 (11) ◽  
pp. e032955
Author(s):  
Masaki Fujiwara ◽  
Masatoshi Inagaki ◽  
Taichi Shimazu ◽  
Masafumi Kodama ◽  
Ryuhei So ◽  
...  

IntroductionOne of the reasons for the high mortality rate from cancer in people with schizophrenia is delay in diagnosis. Many studies have shown lower cancer screening rates in people with schizophrenia; however, there are no interventions for people with schizophrenia to increase cancer screening. Therefore, we developed a case management (CM) intervention to encourage participation in cancer screening. The purpose of this study was to examine the efficacy of CM to encourage participation in cancer screening for people with schizophrenia, with particular focus on colorectal cancer screening by faecal occult blood testing, compared with usual intervention (UI), namely, municipal public education.Methods and analysisThis is an individually randomised, parallel group trial with blinded outcome assessments. The participants will be randomly allocated to either the CM plus UI group or UI alone group in a 1:1 ratio using a web-based program at a data management centre. The primary end point of the study is participation in colorectal cancer screening in the year of intervention, which will be assessed based on municipal records.Ethics and disseminationThis study is performed in accordance with Ethical Guidelines for Medical and Health Research Involving Human Subjects published by Japan’s Ministry of Education, Science, and Technology and the Ministry of Health, Labour, and Welfare and the modified Act on the Protection of Personal Information as well as the Declaration of Helsinki. This study was approved by the institutional ethics committee at the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Hospital on 23 April 2019 (approval number: RIN1904-003). The findings of this trial will be submitted to an international peer-reviewed journal.Trial registration numberUMIN000036017.


2014 ◽  
Vol 24 (2) ◽  
pp. 123-126 ◽  
Author(s):  
Mete Gungor ◽  
Korhan Kahraman ◽  
Esra Ozbasli ◽  
Canan Genim

2002 ◽  
Vol 12 (6) ◽  
pp. 704-709
Author(s):  
Y. Aoki ◽  
T. Sato ◽  
I. Tsuneki ◽  
M. Watanabe ◽  
H. Kase ◽  
...  

We conducted a study of docetaxel-carboplatin combination therapy to confirm the efficacy and toxicity in chemotherapy-naive patients with ovarian cancer. Docetaxel 70 mg/m2 and carboplatin (area under the concentration-vs.-time curve of 5) were administered consecutively on day 1 of a 21-day cycle for five planned cycles in chemo-naive patients with the International Federation of Gynecology and Obstetrics stage IC to IV ovarian cancer with or without successful cytoreductive surgery at staging laparotomy. Twenty-six patients (median age, 53 years; range, 34–76 years) were enrolled into this trial at Niigata University Hospital. The major toxicity with this regimen was neutropenia. The incidence of grade 3 and 4 neutropenia were 27% (7/26) and 69% (18/26), respectively. However, the neutropenia was brief and reversible with G-CSF support. Nausea/emesis, fatigue, arthralgia/myalgias, and alopecia were the most common nonhematologic toxicities, in which no grade 3 or 4 toxicity was observed. Neurotoxicity was infrequently observed. Nine of 11 assessable patients responded to the regimen. We conclude that the combination of carboplatin and docetaxel seems to be highly active in ovarian cancer with the major toxicity of neutropenia, and the extremely low incidence of clinically significant neurotoxicity. Randomized controlled clinical trials should be conducted to define a role for this regimen in ovarian cancer.


2020 ◽  
Vol 31 (2) ◽  
pp. e13-e18
Author(s):  
John W. Lally ◽  
Alexandra Ortiz ◽  
Jon Robitschek ◽  
Michael Demarcantonio

2014 ◽  
Vol 24 (3) ◽  
pp. 594-599 ◽  
Author(s):  
Junjun Yang ◽  
Yang Xiang ◽  
Xirun Wan ◽  
Fengzhi Feng ◽  
Tong Ren

ObjectiveThis study aimed to investigate and analyze the treatments and prognoses of patients with stage IV gestational trophoblastic neoplasia (GTN).MethodsBetween January 1990 and January 2010, 105 patients with stage IV GTN were treated in our hospital (Peking Union Medical College Hospital). A retrospective study is presented herein to report the prognoses of these patients and to statistically analyze the risk factors that affected the prognoses of patients with stage IV GTN.ResultsAfter the treatments, of the 105 patients, 71 (67.6%) patients achieved complete remission, 15 (14.3%) patients exhibited partial remission, and 19 (18.1%) patients exhibited progression of the disease. In total, of the 105 patients, 30 (28.6%) patients died. Our statistical analyses have revealed that a previously failed multidrug chemotherapy history, multiorgan metastasis concomitant with renal metastasis, and surgical intervention all affected the prognoses of patients with stage IV GTN. In addition, patients with stage IV GTN with International Federation of Gynecology and Obstetrics scores below 12 were relatively more likely to obtain complete remission.ConclusionsMultidrug, multiroute chemotherapy, assisted by surgery when necessary, is the predominant strategy for patients with stage IV GTN. Fluorouracil-based multidrug chemotherapy can produce good outcomes for patients with stage IV GTN who were treated primarily. Adequate attention should be given to patients who have previously failed multidrug chemotherapy, have experienced multiorgan metastasis concomitant with renal metastasis, or have International Federation of Gynecology and Obstetrics scores of more than 12.


Sign in / Sign up

Export Citation Format

Share Document